Randomized trial finds rapid antidepressant effects of ketamine in treatment-resistant depression, suggesting NMDA receptor modulation may be a promising approach.
Ketamine demonstrated rapid antidepressant effects in an optimized study design, further supporting NMDA receptor modulation as a novel mechanism for accelerated improvement in severe and chronic forms of depression. More information on response durability and safety is required before implementation in clinical practice.
No takes yet. Share an insight, caveat, or question.
Murrough et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
More from American Journal of Psychiatry